CCY | SZE(M) | TNR | MTY | RNK | MO | SP | FI | TYPE | BNCH | IPT | GDNC | SPRD | CPN | NIC | PRICE |
---|
EUR | 750.000 | 2 | Jun-22 | Sr. Unsecured | Baa3 | BBB- | BBB | Fixed | Swaps | MS+150 a | MS+125 a | 115 | 0.82% | - | 100.00000 |
EUR | 750.000 | 4 | Jun-24 | Sr. Unsecured | Baa3 | BBB- | BBB | Fixed | Swaps | MS+170 a | MS+145 a | 135 | 1.02% | - | 100.00000 |
EUR | 750.000 | 7 | Jun-27 | Sr. Unsecured | Baa3 | BBB- | BBB | Fixed | Swaps | MS+195 a | MS+170 a | 160 | 1.36% | - | 100.00000 |
EUR | 1,250.000 | 12 | Jun-32 | Sr. Unsecured | Baa3 | BBB- | BBB | Fixed | Swaps | MS+235 a | MS+210 a | 195 | 1.91% | - | 100.00000 |
Tranche Comments
2 yr: Book size: 2900; Registration: Reg S Only; Comments: EUR750m 2yr snr unsec RegS. With EUR 4/7/12yr, USD 2-30yr. Baa3/BBB-/BBB. GS(B&D)/BNPP/DB/ING/JPM. IPTs MS+150 area, guidance MS+125 area, launch 750m at MS+115, bk >2.9bn, MWC B+25, no par call. B+146.8 vs BO 0% 6/22 @101.30 HR 98%. LEI: 254900OG32E8F3XO5O83.;
4 yr: Book size: 2600; Registration: Reg S Only; Comments: EUR750m 4yr snr unsec RegS. With EUR 2/7/12yr, USD 2-30yr. Baa3/BBB-/BBB. GS(B&D)/BNPP/DB/ING/JPM. IPTs MS+170 area, guidance MS+145 area, launch 750m at MS+135, bk >2.6bn, 1mPC, MWC B+25. B+168.4 vs OBL 0% 4/24 @ 102.55 HR 100%. LEI: 254900OG32E8F3XO5O83.;
7 yr: Book size: 3300; Registration: Reg S Only; Comments: EUR750m 7yr snr unsec RegS. With EUR 2/4/12yr, USD 2-30yr. Baa3/BBB-/BBB. GS(B&D)/BNPP/DB/ING/JPM. IPTs MS+195 area, guidance MS+170 area, launch 850m @MS+160 , bk >3.3bn, 2mPC, MWC B+30. B+195.7 vs DBR 0.25% 2/27 @ 105.755 HR94%;
12 yr: Book size: 4500; Registration: Reg S Only; Comments: EUR1.25bn 12yr snr unsec RegS. With EUR 2/4/7yr, USD 2-30yr. Baa3/BBB-/BBB. GS(B&D)/BNPP/DB/ING/JPM. IPTs MS+235 area, guidance MS+210 area, launch 1.25bn at MS+195 bk >4.5bn. 3mPC, MWC B+35. DBR 0% Feb-30+233 @ 104.17 HR 105%. LEI: 254900OG32E8F3XO5O83.;
Guarantor(s)
initially by Pfizer